A new DNA encryption approach is being reported as a way to protect engineered cells from tampering and theft by securing biological information “from within.” The work frames protection as part of a broader defensive layer for engineered cell assets, where preventing access or alteration is becoming a practical concern for developers. The concept focuses on cryptographic encoding of DNA instructions embedded in living systems, aiming to make unauthorized changes detectable or ineffective at the cellular level. For regulated therapies, provenance and integrity checks can be as critical as potency and safety. While the underlying technical validation details are not included in the brief, the direction points to a category of biologically native security controls that could complement manufacturing records and chain-of-custody systems. For biotech companies, this raises the bar on thinking about IP security beyond traditional data systems and into biological constructs themselves.